Private drug plans in Canada: H82-22/2016-PDF
cost drivers, 2008 to 2015 = Les facteurs de coût des régimes privés d’assurance-médicaments au Canada, de 2008 à 2015.
"After a few years of slow growth, there has been an increasingly upward pressure on prescription drug spending in Canada. This report analyzes the recent trends in expenditures from the perspective of Canadian private drug plans, with a focus on drug costs in 2015. It explores the drivers of change, identifying the most important cost pressures and measuring their impact on expenditure levels. This study complements the annual PMPRB CompassRx report, which provides a similar analysis of the public drug plan environment. This is one of three reports in a PMPRB series that analyzes the trends in Canadian private drug plans. This series provides policy makers and other stakeholders with valuable insights into the sources of cost pressures in private drug plans and supports them in predicting future trends and identifying cost-saving opportunities."
|Department/Agency||Patented Medicine Prices Review Board.|
|Title||Private drug plans in Canada|
|Subtitle||cost drivers, 2008 to 2015 = Les facteurs de coût des régimes privés d’assurance-médicaments au Canada, de 2008 à 2015.|
|Language||Bilingual-[English | French]|
|Electronic Document|| |
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact the authoring department to request a format other than those available.
We invite you to consult the Frequently Asked Questions page for additional information regarding the Archived Content notice.
Note: The URLs contained in this/these document(s) may no longer be functional
|Note||Caption title. At head of title: National Prescription Drug Utilization Information System.|
|Number of Pages|| p. :|
|Subject Terms||Drug insurance, Prescription drugs, Prices|
- Date modified: